[PDF][PDF] Abatacept therapy reduces CD28+ CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis
S Fukuyo, S Nakayamada, S Iwata, S Kubo… - Clin Exp …, 2017 - clinexprheumatol.org
Clin Exp Rheumatol, 2017•clinexprheumatol.org
Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with
rheumatoid arthritis Page 1 Clinical and Experimental Rheumatology 2017 Clinical and
Experimental Rheumatology 2017; 35: 562-570. Abatacept therapy reduces CD28+CXCR5+
follicular helper-like T cells in patients with rheumatoid arthritis S. Fukuyo, S. Nakayamada, S.
Iwata, S. Kubo, K. Saito, Y. Tanaka The First Department of Internal Medicine, University of
Occupational and Environmental Health, Fukuoka, Japan. Abstract Objective The characteristics …
rheumatoid arthritis Page 1 Clinical and Experimental Rheumatology 2017 Clinical and
Experimental Rheumatology 2017; 35: 562-570. Abatacept therapy reduces CD28+CXCR5+
follicular helper-like T cells in patients with rheumatoid arthritis S. Fukuyo, S. Nakayamada, S.
Iwata, S. Kubo, K. Saito, Y. Tanaka The First Department of Internal Medicine, University of
Occupational and Environmental Health, Fukuoka, Japan. Abstract Objective The characteristics …
Objective
The characteristics of T cells targeted by abatacept (ABT) in cases of rheumatoid arthritis (RA) are still unknown. The goal of the study was to determine the pathogenicity of T cells and the predictors of therapeutic effects of ABT.
clinexprheumatol.org
